BBLG

Bone Biologics Corp

SEC CIK 1419554
$1.25 −18.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
6
Most recent
Advertisement

At a glance

Insiders at BBLG have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Frelick Jeff, BBLG's CEO, spent $6.5K of their own money on 9,500 shares at $1, growing their stake 123%.

Most active filer: Walsh Deina H, with 3 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for BBLG, newest first
View on SEC EDGAR ↗
BBLG
Buy Walsh Deina H · Chief Financial Officer · Open-market purchase · filed Sep 14, 2023 ΔOwn +114%

Walsh Deina H, BBLG's CFO, spent $5.1K of their own money on 8,000 shares at $1, growing their stake 114%.

+$5.1K
8,000 sh @ $1
BBLG
Buy Frelick Jeff · Chief Executive Officer · Open-market purchase · filed Sep 12, 2023 ΔOwn +123%

Frelick Jeff, BBLG's CEO, spent $6.5K of their own money on 9,500 shares at $1, growing their stake 123%.

+$6.5K
9,500 sh @ $1
BBLG
Buy Walsh Deina H · Chief Financial Officer · Open-market purchase · filed Sep 7, 2023 ΔOwn NEW

Walsh Deina H, BBLG's CFO, spent $210 of their own money on 300 shares at $1, opening a brand-new position.

+$210
300 sh @ $1
BBLG
Buy Walsh Deina H · Chief Financial Officer · Open-market purchase · filed Sep 7, 2023 ΔOwn +999%

Walsh Deina H, BBLG's CFO, spent $4.8K of their own money on 6,700 shares at $1, growing their stake 2233%.

+$4.8K
6,700 sh @ $1
Advertisement
BBLG
Buy Frelick Jeff · Chief Executive Officer · Open-market purchase · filed Sep 5, 2023 ΔOwn +999%

Frelick Jeff, BBLG's CEO, spent $5K of their own money on 7,600 shares at $1, growing their stake 7308%.

+$5K
7,600 sh @ $1
BBLG
J Hankey Don · Director, Chairman of the Board, 10% Owner · Other · filed Mar 29, 2023 ΔOwn −100%
−$0
500,137 sh
Advertisement

About BBLG insider activity

This page tracks every recent Form 4 filed for Bone Biologics Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is BBLG insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Bone Biologics Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.